Similar Papers

Paper Title
Journal
Date
Author
Subtractive Genomics Approach for Identification of Novel Therapeutic Drug Targets in Mycoplasma genitalium
Abiodun Joseph Fatoba ... Matthew Adekunle Adeleke
Pathogens | VOL. 10
Abiodun Joseph Fatoba, et. al.Abiodun Joseph Fatoba ... Matthew Adekunle Adeleke
21 Jul 2021
Comment on "current understanding of ZIP and ZnT zinc transporters in human health and diseases".
Javier Costas
Cellular and Molecular Life Sciences | VOL. 72
Javier CostasJavier Costas
01 Oct 2014
Recent Development in Identification of Potential Novel Therapeutic Targets Against Trypanosomatids.
Rajender Kumar ... Deepak Kumar Gaur
Current topics in medicinal chemistry | VOL. 16
Rajender Kumar, et. al.Rajender Kumar ... Deepak Kumar Gaur
30 May 2016
Core proteome mediated subtractive approach for the identification of potential therapeutic drug target against the honeybee pathogen Paenibacillus larvae.
Sawsen Rebhi ... Hanen Najjaa
PeerJ | VOL. 12
Sawsen Rebhi, et. al.Sawsen Rebhi ... Hanen Najjaa
27 May 2024
View more papers

More From: Journal of Translational Medicine

Paper Title
Journal
Date
Author
Does preeclampsia impact the gut microbiota of preterm offspring during early infancy?
Yang Chen ... Li-Juan Lv
Journal of Translational Medicine | VOL. 23
Yang Chen, et. al.Yang Chen ... Li-Juan Lv
19 Jan 2025
KEAP1 mutations as key crucial prognostic biomarkers for resistance to KRAS-G12C inhibitors
Linyan Tian ... Yan Wang
Journal of Translational Medicine | VOL. 23
Linyan Tian, et. al.Linyan Tian ... Yan Wang
17 Jan 2025
PRDX2 induces tumor immune evasion by modulating the HDAC3-Galectin-9 axis in lung adenocarcinoma cells
Yunjia Dong ... Jing Wu
Journal of Translational Medicine | VOL. 23
Yunjia Dong, et. al.Yunjia Dong ... Jing Wu
17 Jan 2025
Parthenolide improves sepsis-induced coagulopathy by inhibiting mitochondrial-mediated apoptosis in vascular endothelial cells through BRD4/BCL-xL pathway
Jun Zhang ... Qingxiang Mao
Journal of Translational Medicine | VOL. 23
Jun Zhang, et. al.Jun Zhang ... Qingxiang Mao
17 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.